CompoAtlas

Eros

Food supplement declared in France, declaration No 2017-11-375

Eros is a food supplement declared in France. Status: retrait du marché annoncé pour le 1 July 2027. 2 points in its composition require a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Pharm & nature
Status
Retrait du marché annoncé pour le 1 July 2027
Form
Gélule
Daily dose
4 gélules
Directions for use
Prendre 2 à 4 gélules par jour
Objectives stated by the manufacturer (these are not authorised claims)
Tonus sexuel

Declaration 152169, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Lepidium meyenii Walp.RacineExtrait sec aqueux480 mg
Ptychopetalum olacoides Benth.EcorceExtrait sec aqueux120 mg

Other active ingredients

NamePer day
Taurinenot declared
Gelée royale lyophiliséenot declared

Additives

E171, E470b

Other ingredients

gélatine, maltodextrine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Complément alimentaire, ne peut être substitué à un régime alimentaire varié et équilibré. A prendre dans le cadre d'un mode de vie sain. Tenir hors de portée des enfants. Ne pas dépasser la dose journalière recommandée. A conserver dans un endroit sec et à l'abri de la lumière.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line